0001209191-21-002418.txt : 20210106
0001209191-21-002418.hdr.sgml : 20210106
20210106211209
ACCESSION NUMBER: 0001209191-21-002418
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210104
FILED AS OF DATE: 20210106
DATE AS OF CHANGE: 20210106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Camardo Daniel A.
CENTRAL INDEX KEY: 0001820365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 21512740
MAIL ADDRESS:
STREET 1: C/O HORIZON THERAPEUTICS, PLC
STREET 2: CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
CITY: DUBLIN
STATE: L2
ZIP: D04 C5Y6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-04
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001820365
Camardo Daniel A.
C/O HORIZON THERAPEUTICS PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
0
1
0
0
EVP and President, U.S.
Ordinary Shares
2021-01-05
4
M
0
20614
A
52513
D
Ordinary Shares
2021-01-05
4
F
0
9230
73.28
D
43283
D
Restricted Stock Units (RSU)
2021-01-04
4
A
0
20957
0.00
A
Ordinary Shares
20957
20957
D
Restricted Stock Units (RSU)
2021-01-05
4
M
0
5634
0.00
D
2021-01-05
2021-01-05
Ordinary Shares
5634
0
D
Restricted Stock Units (RSU)
2021-01-05
4
M
0
10626
0.00
D
Ordinary Shares
10626
10626
D
Restricted Stock Units (RSU)
2021-01-05
4
M
0
4354
0.00
D
Ordinary Shares
4354
8708
D
Each RSU represents a contingent right to receive one ordinary share of the Issuer.
Includes 1,070 ordinary shares of the Issuer acquired by the reporting person on December 1, 2020 pursuant to an employee stock purchase program.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2020.
The RSU's vest 1/3rd annually on each anniversary of January 5, 2019.
/s/ Miles W. McHugh, Attorney-in-Fact
2021-01-06